Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HILP with Melphalan +/- TNF for Extremity Melanoma
NCT00003789Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 1999
- Primary completion
- Jan 2004
- Modality
- Gene Editing, Gene Silencing, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of tumor necrosis factor-α in melanoma, sponsored by National Cancer Institute. Started Mar 1999; status: completed.
02
Drugs
tumor necrosis factor-α
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00003789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003789.